Related references
Note: Only part of the references are listed.TERTpromoter mutations in primary and secondary WHO grade III meningioma
Andrea Daniela Maier et al.
BRAIN PATHOLOGY (2021)
Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis
Christian Mirian et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
CDKN2A/Bhomozygous deletion is associated with early recurrence in meningiomas
Philipp Sievers et al.
ACTA NEUROPATHOLOGICA (2020)
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
Erik A. Williams et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome
Annamaria Biczok et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors
Matthieu Peyre et al.
NEURO-ONCOLOGY (2018)
TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas
Annamaria Biczok et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma
Sabine Spiegl-Kreinecker et al.
NEURO-ONCOLOGY (2018)
TERT Alterations in Progressive Treatment-Resistant Meningiomas
Tareq A. Juratli et al.
NEUROSURGERY (2018)
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome
Tareq A. Juratli et al.
ACTA NEUROPATHOLOGICA (2018)
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
Felix Sahm et al.
LANCET ONCOLOGY (2017)
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
Tareq A. Juratli et al.
ONCOTARGET (2017)
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Felix Sahm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Felix Sahm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
High Incidence of Activating TERT Promoter Mutations in Meningiomas Undergoing Malignant Progression
Stephane Goutagny et al.
BRAIN PATHOLOGY (2014)
Share Paper
